Is β- amyloid a reliable marker for assessing neurocognitive functions in middle-aged OSAS patients??
Sleep and Breathing · 2025
DOI: 10.1007/s11325-025-03353-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sleep and Breathing, 2025. Verfasst von Büşra Durak und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chest Disease, Çorum Hitit University Faculty of Medicine, Corum, Türkiye. drbusradurak@gmail.com. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Amyloid beta-Peptides, Cognitive Dysfunction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chest Disease, Çorum Hitit University Faculty of Medicine, Corum, Türkiye. drbusradurak@gmail.com.
- Department of Chest Diseases, University of Health Sciences, Sureyyapasa Training and Research Hospital, İstanbul, Türkiye.
- Department of Internal Medicine, University of Health Sciences, Sureyyapasa Training and Research Hospital, İstanbul, Türkiye.
ORCID-Profile: Büşra Durak
Zitieren
APA
Durak, B., Özol, D., Durak, İ., & Saraç, S. (2025). Is β- amyloid a reliable marker for assessing neurocognitive functions in middle-aged OSAS patients??. Sleep and Breathing. https://doi.org/10.1007/s11325-025-03353-9
Vancouver
Durak B, Özol D, Durak İ, Saraç S. Is β- amyloid a reliable marker for assessing neurocognitive functions in middle-aged OSAS patients??. Sleep and Breathing. 2025. doi:10.1007/s11325-025-03353-9
BibTeX
@article{Durak2025,
author = {Durak, Büşra and Özol, Duygu and Durak, İbrahim and Saraç, Sema},
title = {Is β- amyloid a reliable marker for assessing neurocognitive functions in middle-aged OSAS patients??},
journal = {Sleep and Breathing},
year = {2025},
doi = {10.1007/s11325-025-03353-9}
}
EUVIMED